Indications for cardiac defibrillators in patients with congestive heart failure

Isaac Pourati1, Lawrence Rosenthal

  • 1Department of Medicine, Division of Cardiovascular Medicine, Cardiac Pacing and Electrophysiology, UMass Memorial Medical Center, 55 Lake Avenue North, Worcester, MA 01655, USA.

Insights

Sudden cardiac death (SCD) is a major risk for heart failure patients. Implantable cardiac defibrillators (ICDs) are proven to prevent SCD, with trials expanding their use for primary prevention.

Area of Science:

  • Cardiology
  • Medical Devices
  • Clinical Trials

Background:

  • Sudden cardiac death (SCD) is a leading cause of mortality in heart failure patients.
  • Left ventricular dysfunction is a key risk factor associated with SCD.
  • Implantable cardiac defibrillators (ICDs) offer a therapeutic intervention for SCD prevention.

Purpose of the Study:

  • To review clinical trials that have shaped current practice guidelines for ICD implantation.
  • To highlight the evolution of ICD indications from secondary to primary prevention of SCD.
  • To discuss the role of device therapy in managing patients at risk for SCD.

Main Methods:

  • Systematic review of pivotal clinical trials.
  • Analysis of patient populations and outcomes related to ICD therapy.
  • Evaluation of evidence supporting current guidelines for SCD prevention.

Main Results:

  • Clinical trials have demonstrated the efficacy of ICDs in reducing SCD incidence.
  • Evidence supports the expansion of ICD use for primary prevention in selected heart failure patients.
  • Current guidelines incorporate device therapy based on trial data.

Conclusions:

  • Implantable cardiac defibrillators are crucial for preventing sudden cardiac death in heart failure.
  • Ongoing research and clinical trials continue to refine patient selection for ICD therapy.
  • Device therapy plays a vital role in the management of cardiovascular mortality.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...